3rd Annual Clinical Trials in Rare Diseases 2025

Aixial Group at the Forefront of Rare Disease Clinical Trials

Aixial Group is proud to participate in the 3rd Annual Clinical Trials in Rare Diseases 2025, taking place on September 17-18, 2025, at the Marriott Princeton at Forrestal, Princeton, USA. We understand that rare disease trials present unique challenges, and with more than 20 years of experience, Aixial is expertly equipped to navigate them.

Mark your calendars for Day 1 at 12:15, as our Senior Director, Clinical Operations & Project Management, Jim Lincoln, will be delivering a presentation on our specialised approach to rare disease clinical trials. Our rare disease-experienced teams are dedicated to providing proactive risk identification and mitigation strategies specific to your target indication, ensuring your trials run smoothly and efficiently.

Join us to discover how Aixial Group’s deep understanding and tailored solutions can accelerate your rare disease clinical development.